Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, Oct. 02, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
Date | Total number of shares in the capital | Total number of voting rights |
09/30/2024 | 100,093,873 | 88,569,683 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com
Attachment
Upcoming Life Sciences Events
- November 2024
- Philadelphia: Advanced Therapies USA
- London: Inv€$tival Showcase
- EABR Nanoparticles Platform for Hybrid mRNA Vaccine